SABCS 2018 - oncoletter€¦ · committee member for the IMpassion130 and KATE2 trials This study...

10
SABCS 2018

Transcript of SABCS 2018 - oncoletter€¦ · committee member for the IMpassion130 and KATE2 trials This study...

Page 1: SABCS 2018 - oncoletter€¦ · committee member for the IMpassion130 and KATE2 trials This study is sponsored by F. Hoffmann-La Roche, Ltd Editorial support, funded by the sponsor,

SABCS 2018

Page 2: SABCS 2018 - oncoletter€¦ · committee member for the IMpassion130 and KATE2 trials This study is sponsored by F. Hoffmann-La Roche, Ltd Editorial support, funded by the sponsor,

SABCS 2018

Page 3: SABCS 2018 - oncoletter€¦ · committee member for the IMpassion130 and KATE2 trials This study is sponsored by F. Hoffmann-La Roche, Ltd Editorial support, funded by the sponsor,

SABCS 2018

Page 4: SABCS 2018 - oncoletter€¦ · committee member for the IMpassion130 and KATE2 trials This study is sponsored by F. Hoffmann-La Roche, Ltd Editorial support, funded by the sponsor,

SABCS 2018

Page 5: SABCS 2018 - oncoletter€¦ · committee member for the IMpassion130 and KATE2 trials This study is sponsored by F. Hoffmann-La Roche, Ltd Editorial support, funded by the sponsor,

SABCS 2018

Page 6: SABCS 2018 - oncoletter€¦ · committee member for the IMpassion130 and KATE2 trials This study is sponsored by F. Hoffmann-La Roche, Ltd Editorial support, funded by the sponsor,

SABCS 2018

Page 7: SABCS 2018 - oncoletter€¦ · committee member for the IMpassion130 and KATE2 trials This study is sponsored by F. Hoffmann-La Roche, Ltd Editorial support, funded by the sponsor,

SABCS 2018

Page 8: SABCS 2018 - oncoletter€¦ · committee member for the IMpassion130 and KATE2 trials This study is sponsored by F. Hoffmann-La Roche, Ltd Editorial support, funded by the sponsor,

SABCS 2018

Page 9: SABCS 2018 - oncoletter€¦ · committee member for the IMpassion130 and KATE2 trials This study is sponsored by F. Hoffmann-La Roche, Ltd Editorial support, funded by the sponsor,

SABCS 2018

Page 10: SABCS 2018 - oncoletter€¦ · committee member for the IMpassion130 and KATE2 trials This study is sponsored by F. Hoffmann-La Roche, Ltd Editorial support, funded by the sponsor,

SABCS 2018